Bailard’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-35,133
Closed -$117K 837
2024
Q3
$117K Sell
35,133
-5,767
-14% -$19.3K ﹤0.01% 726
2024
Q2
$122K Hold
40,900
﹤0.01% 707
2024
Q1
$141K Buy
+40,900
New +$141K ﹤0.01% 714
2023
Q2
Sell
-21,200
Closed -$39.2K 790
2023
Q1
$39.2K Hold
21,200
﹤0.01% 707
2022
Q4
$40.9K Buy
+21,200
New +$40.9K ﹤0.01% 698